Dopamine Impurity 33 is a fully characterized chemical compound used as a reference standard of API Dopa. The standard offered is compliant with regulatory guidelines. Dopamine Impurity 33 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Levodopa EP Impurity D (3,4-Dihydroxy-D-Phenylalanine)
M.F.
M.W. 197.19
CAT# AR-D02195
CAS# 5796-17-8
Levodopa EP Impurity C HCl (Levodopa USP Related Compound B HCl, DL-3-O-Methyldopa HCl)
M.F.
M.W. 211.22 36.46
CAT# AR-D07585
CAS# 91013-37-5
Levodopa EP Impurity C Sodium Salt (Levodopa USP Related Compound B Sodium Salt , DL-3-O-Methyldopa Sodium Salt )
M.F.
M.W. 210.21 22.99
CAT# AR-D07587
CAS# NA
Methyldopa EP Impurity D HCl (Carbidopa Impurity 3 HCl)
M.F.
M.W. 211.22 36.46
CAT# AR-D07580
CAS# 1369423-51-7
Droxidopa Impurity 7-13C-d3 HCl
M.F.
M.W. 231.23 36.46
CAT# AR-D02265
CAS# 39846-91-8 (non-labelled, free base)
